Asia Pacific Allergy Immunotherapy Market Size & Outlook
Related Markets
Asia Pacific allergy immunotherapy market highlights
- The Asia Pacific allergy immunotherapy market generated a revenue of USD 129.0 million in 2024.
- The market is expected to grow at a CAGR of 12% from 2025 to 2030.
- In terms of segment, subcutaneous immunotherapy was the largest revenue generating treatment type in 2024.
- Subcutaneous immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 129.0 million |
| Market revenue in 2030 | USD 255.9 million |
| Growth rate | 12% (CAGR from 2025 to 2030) |
| Largest segment | Subcutaneous immunotherapy |
| Fastest growing segment | Subcutaneous immunotherapy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Subcutaneous immunotherapy, Sublingual immunotherapy |
| Key market players worldwide | Merck KGaA, Allergy Therapeutics PLC, DBV Technologies SA ADR, ASIT biotech, Circassia, Mylan, DMK Pharmaceuticals Corp, Alk-Abello A/S Class B, Desentum, HAL Allergy Group, HollisterStier Allergy, Stallergenes Greer |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 6.7% of the global allergy immunotherapy market in 2024.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 255.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Allergy Immunotherapy Market Scope
Allergy Immunotherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Stallergenes Greer | View profile | 1001-5000 | London, England, United Kingdom, Europe | http://stallergenesgreer.com/ |
| DMK Pharmaceuticals Corp | View profile | 12 | 11682 El Camino Real, Suite 300, San Diego, CA, United States, 92130 | https://www.adamispharmaceuticals.com |
| HollisterStier Allergy | View profile | 251-500 | Spokane, Washington, United States, North America | https://www.hsallergy.com |
| HAL Allergy Group | View profile | 251-500 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.hal-allergy.com/ |
| Desentum | View profile | 1-10 | Espoo, Southern Finland, Finland, Europe | http://www.desentum.fi/en/ |
| Circassia | View profile | 51-100 | Oxford, Oxfordshire, United Kingdom, Europe | http://www.circassia.com/ |
| ASIT biotech | View profile | 11-50 | Brunelles, Centre, France, Europe | https://www.asitbiotech.com/ |
| Alk-Abello A/S Class B | View profile | 2828 | Boge Alle 6-8, Horsholm, Denmark, DK-2970 | https://www.alk.net |
| Mylan | View profile | 10001+ | https://www.mylan.in/ | |
| Allergy Therapeutics PLC | View profile | 612 | Dominion Way, Worthing, West Sussex, United Kingdom, BN14 8SA | https://www.allergytherapeutics.com |
| DBV Technologies SA ADR | View profile | 105 | 177-181 avenue Pierre Brossolette, Montrouge, France, 92120 | http://www.dbvtechnologies.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Asia Pacific allergy immunotherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to allergy immunotherapy market will help companies and investors design strategic landscapes.
Subcutaneous immunotherapy was the largest segment with a revenue share of 74.81% in 2024. Horizon Databook has segmented the Asia Pacific allergy immunotherapy market based on subcutaneous immunotherapy, sublingual immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Asia Pacific allergy immunotherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific allergy immunotherapy market databook
-
Our clientele includes a mix of allergy immunotherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific allergy immunotherapy market, including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific allergy immunotherapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific allergy immunotherapy market size, by country, 2018-2030 (US$M)
Asia Pacific Allergy Immunotherapy Market Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
